Zhejiang Gongdong Medical Technology (605369.SH) plans to spend 45.65 million yuan to acquire a 55% stake in Jindongsheng to expand sales channels in the northwest region.

Zhejiang Gongdong Medical Technology (605369.SH) announced that, based on the company's business strategy and development plan, in order to further expand sales channels in the northwest region and enhance market share, the company signed a "Zhejiang Gongdong Medical Technology Co., Ltd. and Liu Dongming on the Equity Transfer Agreement of Urumqi Jindongsheng Trading Co., Ltd." with Liu Dongming and Urumqi Jindongsheng Trading Co., Ltd. ("Jindongsheng") on January 10, 2025. The company plans to acquire 55% of Jindongsheng's equity held by Liu Dongming for 45.65 million yuan of its own funds, corresponding to a registered capital of 5.5 million yuan. After this investment is completed, the company will hold 100% of Jindongsheng's shares, making Jindongsheng a wholly-owned subsidiary of the company.